Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Carlos Galvani

Surgery New Orleans, LA Medical Doctor

NPI 1003916883 CMS profile 226949

1415 Tulane Ave, New Orleans, LA 70112

Open in the dashboard

General payments

$352,066

489 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Carlos Galvani of New Orleans, LA is reported in the CMS Open Payments database as having received $352,066 across 489 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,102 36
2024 General $46,229 76
2023 General $61,909 72
2022 General $83,610 128
2021 General $19,314 32
2020 General $42,326 42
2019 General $88,576 103

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carlos Galvani
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Carlos Galvani were reported at $10,102. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Carlos Galvani Surgery median Middle half National median
2019 $88,576 $253 $82–$1,521 $163
2020 $42,326 $131 $40–$706 $114
2021 $19,314 $168 $50–$904 $132
2022 $83,610 $224 $76–$1,218 $149
2023 $61,909 $253 $82–$1,255 $160
2024 $46,229 $279 $90–$1,381 $164
2025 $10,102 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $178,165 257 payments
  2. W. L. Gore & Associates, Inc. $102,947 123 payments
  3. Davol Inc. $57,816 44 payments
  4. Covidien LP $6,158 10 payments
  5. Medtronic, Inc. $4,978 26 payments
  6. Ethicon US, LLC $1,032 12 payments
  7. Endogastric Solutions, Inc $200 4 payments
  8. Enterra Medical, Inc. $153 1 payment
  9. C. R. Bard, Inc. & Subsidiaries $149 1 payment
  10. Philips Electronics North America Corporation $149 1 payment
  11. Other $320 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $79,769 26 payments
  2. Consulting Fee $74,630 27 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $73,040 35 payments
  4. Honoraria $70,485 15 payments
  5. Travel and Lodging $34,429 137 payments
  6. Food and Beverage $19,700 248 payments
  7. Gift $14 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $155,615 243 payments
  2. GORE SEAMGUARD Bioabsorbable Staple Line Reinforce $41,382 54 payments
  3. PHASIX $29,315 19 payments
  4. DA VINCI SP $22,550 14 payments
  5. SEAMGUARD Staple Line Reinforcement $21,514 9 payments
  6. GORE ENFORM Preperitoneal Biomaterial $14,427 8 payments
  7. GORE BIO-A Tissue Reinforcement $14,160 6 payments
  8. GORE MYCROMESH Biomaterial $10,620 1 payment
  9. BIO-A Tissue Reinforcement $10,588 16 payments
  10. GORE ENFORM Biomaterial $8,315 2 payments
  11. Other $21,420 112 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$10,885

Medicare's payments for the services billed

Medicare patients

17

Average age 71

Services billed

49

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

489 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record